Charakterisierung der  lokalen Kontrolle des Stoffwechsels  und der Durchblutung  im subkutanen FettgewebeFrauke Adams1121.134561.2781.39101.411121322.1142.22.32.3.11516172.3.2182.3.31920212223242.3.42.3.4.12.3.4.2252.3.4.32.3.5262.3.62.42.4.1272.4.22.52.5.12.5.2282.62.6.1293031322.733342.83533.13.1.13536373.1.2383.23.2.1393.2.240413.2.342433.2.43.2.544453.2.646473.2.748493.2.850513.2.952533.33.3.1543.3.255563.43.4.1573.4.258593.4.3606144.161626364654.266674.368694.47071572736. Literaturverzeichnis AbkürzungsverzeichnisDanksagungPreise Vorträge PosterEidesstattliche ErklärungdeInhaltsverzeichnisHilfe 6. Literaturverzeichnis

1. Wechsler JG (Herausgeber). Adipositas - Ursachen und Therapie. Blackwell Verlag GmbH

Berlin
2003.

2. Wirth A (Herausgeber). Adipositas-Fibel. Springer-Verlag

Berlin-Heidelberg
1998.

3. Stich V und Berlan M. Physiological regulation of NEFA availability: lipolysis pathway. Proc Nutr Soc 2004; 63: 369-374.

4. Engeli S, Gorzelniak K, Kreutz R et al. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 1999; 17: 555-560.

5. English V und Cassis L. Fascilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J Neural Transm 1999; 106: 631-644.

6. Enoksson S, Nordenstrom J, Bolinder J. Influence of local blood flow on glycerol levels in human adipose tissue. Int J Obes Metab Disord 1995; 19: 350-354.

7. DiGirolamo M, Skinner NS, Hanley HG et al. Relationship of adipose tissue blood flow to fat cell size and number. Int J Physiol 1971; 220: 932-937.

8. Hagström-Toft E, Enoksson S, Moberg E et al. Beta-adrenergic regulation of lipolysis and blood flow in human skeletal muscle in-vivo. Am J Physiol 1998; 275: 909-916.

9. Kelley DE, Goodpaster BH und Storlien L. Muscle triglyceride and insulin. Annu Rev Nutr 2002; 22: 325-346.

10. Tschöp M und Heiman ML. Rodent obesity models: an overview. Exp Clin Endocrinol Diabetes 2001; 109: 307-319.

11. Rayner DV. The sympathetic nervous system in white adipose tissue regulation. Proceed Nutr Soc 2001; 60: 357-364.

12. Engeli S, Schling P, Gorzelniak K et al. The adipose tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?. Int J Biochem Cell Biol 2003; 35: 807-825.

13. Forth W, Henschler D, Rummel W (Herausgeber). Allgemeine und spezielle Pharmakologie und Toxikologie, 8. Auflage, Urban und Fischer Verlag 2004.

14. Boschmann M. Heterogeneity of adipose tissue metabolism. In: Klaus S (Herausgeberin), Adipose tissue.

Georgetown
, TX: Landes Bioscience 2001; 131-157.

15. Enoksson S, Shimizu M, Lönnqvist F et al. Demonstration of an in-vivo functional beta-3-adrenoceptor in man. J Clin Invest 1995; 95: 2239-2245.

16. Lafontan M, Barbe P, Galitzky J et al. Adrenergic regulation of adipocyte metabolism. Hum Reprod 1997; 12: 6-20.

17. Barbe P, Millet L, Galitzky J et al. In situ assessment of the role of the beta 1-, beta 2-, and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol 1996; 117: 907-913.

18. Krief S, Lönnqvist F, Raimbault S et al. Tissue distribution of the beta 3-adrenergic in man. J Clin Invest 1993; 91: 344-349.

19. Faintrenie G und Géloen A. Alpha 1-regulation of lactate production by white adipocytes . J Pharm Exp Ther 1996; 277: 235-238.

20. Leibel R und Hirsch J. Site- and sex-related difference in adrenoceptor status of human adipose tissue. J Clin Endocrinol Metab 1987; 64: 1205-1210.

21. Lönnqvist F, Thorne A, Large V et al. Sex differences in visceral fat lipolysis and metabolic complications in obesity. Arterioscler Thromb Vasc Biol 1997; 17: 1472-1480.

22. Boschmann M, Schröder C, Christensen NJ et al. Norepinephrine transporter function and autonomic control of metabolism. J Clin Endocrinol Metab 2002; 87: 5130-5137.

23. Iversen L. Neurotransmitter transporters: Fruitful targets for CNS drug discovery. Mol Psychiatry 2000; 5: 357-362.

24. Galli A, Blakely RD und DeFelice LJ. Norepinephrine transporters have channel modes of conduction. Proc Natl Acad Sci USA 1996; 93: 8671-8676.

25. Tejani-Butt SM und Yang J. a time course of altered thyroid states on the noradrenergic system in rat brain by quantitative autoradiography. Neuroendocrinology 1994; 59: 235-244.

26. Figlewicz DP. Endocrine regulation of neurotransmitter transporters. Epilepsy Res 1999; 37: 203-210.

27. Shang Y und Dluzen DE. Castration increases nisoxetine-evoked norepinephrine levels in vivo within the olfactory bulb of male rats. Neurosci Lett 2002; 328: 81-84.

28. Yang SP, Pau KY und Spies HG. Gonadectomy alters tyrosine hydroxylase and norepnephrine transporter mRNA levels in the locus coeruleus in rabbits. J Neuroendocrinol 1997; 9: 763-768.

29. Jacob G und Biaggioni I. Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sci 1999; 317: 88-101.

30. Shannon JR, Flattem NL, Jordan J et al. Orthostatic intolerance and tachycardia associated with norepinephrine transporter defiency. N Engl J Med 2000; 342: 541-549.

31. Timmermans PBMWM, Wong PC, Chiu AT et al. Angiotensin receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45: 205-251.

32. Jones A und Woods DR. Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol 2003; 35: 855-866.

33. Schütz S, Le Moullec JM, Corvol P et al. Early expression of all the components of the renin-angiotensin-system in human development. Am J Pathol 1996; 149: 2067-2079.

34. Engeli S, Negrel R und Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000; 35: 1270-1277.

35. Cassis LA, Marshall DE, Fettinger MJ et al. Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol 1998; 274: E867-E876.

36. Brink M, Wellen J und Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressure-independent mechanism. J Clin Invest 1996; 97: 2509-2516.

37. Harrison-Bernard LM, El-Dahr SS, O´Leary DF et al. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 1999; 33: 340-346.

38. Cassis LA und Dwoskin LP. Presynaptic modulation of neurotransmitter release by endogeneous angiotensin II in brown adipose tissue. J Neural Transm Suppl 1991; 34: 129-137.

39. Cassis LA und Dwoskin LP. Acute and chronic losartan administration: effect on angiotensin II content and modulation of [3H]norepinephrine release from rat interscapular brown adipose tissue. J Neural Transm Gen Sect 1994; 98: 159-164.

40. Cabassi A, Coghi P, Govoni P et al. Sympathetic modulation by carvediol and losartan reduces angiotensin II - mediated lipolysis in subcutaneous and visceral fat. J Clin Endocrinol Metab 2005; 90: 2888-2897.

41. Axelrod L, Minnich AK und Ryan CA. Stimulation of prostacyclin production in isolated rat adipocytes by angiotensin II, vasopressin, and bradykinin: evidence for two separate mechanisms of prostaglandin synthesis. Endocrinology 1985; 116: 2548-2553.

42. Darimont C, Vassaux G, Gaillard D et al. In situ microdialysis of prostaglandins in adipose tissue: stimulation of PGI2 release by angiotensin II. Int J Obes 1994; 18: 783-788.

43. Adams F, Klaus S und Boschmann M. Metabolic and hemodynamic response to angiotensin II in rat adipose tissue (Abstract). Int J Obes Relat Metab Disord 2000; 24.

44. Jones BH, Standridge MK und Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997; 138: 1512-1519.

45. McGrath BP, Matthews PG, Louis W et al . Double blind study of dilevalol and captopril, both in combination with hydrochlorothiazide, in patients with moderate to severe hypertension. J Cardiovasc Pharmacol 1990; 16: 831-838.

46. Campbell DJ, Duncan AM, Kladis A et al. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1995; 26: 426-436.

47. Goossens GH, Blaak EE, Saris WHM et al. Angiotensin II induced effects on adipose tissue and skeletal muscle blood flow and lipolysis in normal-weight and obese subjects. J Clin Endo Metab 2004; 89: 2690-2696.

48. Shiuchi T, Iwai M, Li HS et al. Angiotensin II type 1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic rats. Hypertension 2004; 43: 1003-1010.

49. Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms. Diabetes Metab 2004; 30: 498-505.

50. Schoonen AJM und Wientjes KJC. A model for transport of glucose in adipose tissue to a microdialysis probe. Diabetes Technology & Therapeutics 2003; 5: 589-598.

51. Daig R, Staiger H und Löffler G. Pathophysiologie des Fettgewebes. Ernährungsumschau 1999; 46: 208-214.

52. Björntorp P und Sjöström L. Number and size of adipose tissue fat cells in relation to metabolism in human obesity. Metabolism 1971; 20: 703-713.

53. Crandall DL, Goldstein BM, Lizzo FH et al. Hemodynamics to obesity: influence of pattern of adipose tissue cellularity. Am J Physiol 1986; 251: 314-319.

54. Blaak EE, van Baak MA, Kemerink GJ et al. Beta-adrenergic stimulation and abdominal subcutaneous fat blood flow in lean, obese, and reduced-obese subjects. Metabolism 1995; 44: 183-187.

55. Bolinder J, Kerckhoffs DA, Moberg E et al. Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects. Diabetes 2000; 49: 797-802.

56. Jansson P, Larsson A, Smith U et al . Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest 1992; 89: 1610-1617.

57. Summers LK, Samra JS, Humphreys SM et al. Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin Sci Colch 1996; 91: 679-683.

58. Tomanek RJ, Palmer PJ, Pfeiffer GL et al. Morphometry of canine coronary arteries, arterioles, and capillaries during hypertension and left ventricular hypertrophy. Circ Res 1986; 58: 38-46.

59. Després JP, Prud´homme D, Pouliot MC et al. Estimation of deep abdominal adipose tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 1991; 54: 471-477.

60. Fischer M, Baessler A und Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 2002; 53: 672-677.

61. Lönnroth P und Smith U. Microdialysis - a novel technique for clinical investigations. J Intern Med 1990; 227: 295-300.

62. Ungerstedt U. Microdialysis - principles and applications for studies in animals and man. J Intern Med 1991; 230: 365-373.

63. Jacob J, Gamboa A, Diedrich A et al. Tyramine-induced vasodilation mediated by dopamine contamination: a paradox resolved. Hypertension 2005; 46: 355-359.

64. Gronlund B, Astrup A, Bie P et al . Noradrenalin release in skeletal muscle and in adipose tissue studied by microdialysis . Clin Sci (Lond) 1991; 80: 595-598.

65. Jordan J, Tank J, Christensen NJ et al. Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrin Metab 2001; 86: 2803-2810.

66. Boschmann M, Ringel J, Klaus S et al. Metabolic and hemodynamic response of adipose tissue to angiotensin II. Obes Res 2001; 9: 486-491.

67. Grassi G, Seravalle G, Calhoun DA et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994; 90: 248-253.

68. Darimont C, Delansorne R, Paris J et al. Influence of estrogenic status on the lipolytic activity of parametrial adipose tissue in-vivo: an in-situ microdialysis study. Endocrinology 1997; 138: 1092-1096.

69. Knußmann R. Anthropologie. Handbuch der vergleichenden Biologie des Menschen. Band I (1). Fischer Verlag

Stuttgart
1988.

70. Holmes C, Eisenhofer G und Goldstein DS. Improved assay for plasma dihydroxyphenyacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 1994; 653: 131-138.

71. Goldstein DS, Holmes C, Jacob G et al. Vasodilation during systemic tyramine administration. Circulation 2004; 109: E17-E18.

72. Thompson GE. Dopamine and lipolysis in adipose tissue of the sheep. Quart J Exp Physiol 1984; 69: 155-159.

73. Nisoli E, Tonello C, Memo M et al. Biochemical functional identification of a novel dopamine receptor subtype in rat brown adipose tissue. Its role in modulating sympathetic stimulation-induced thermogenesis. J Pharmacol Exp Ther 1992; 263: 823-829.

74. Hickner RC, Rosdahl H, Borg I et al. The ethanol technique of monitoring local blood flow in rat skeletal muscle: implications for microdialysis. Acta Physiol Scan 1992; 146: 87-97.

75. Karpe F, Fielding BA, Ilic V et al. Monitoring adipose tissue blood flow in man: a comparison between the (133)xenon washout method and microdialysis. Int J Obes Relat Metab Disord 2002; 26: 1-5.

76. Hickner RC, Bone D, Ungerstedt U et al. Muscle blood flow during intermittent exercise: comparison of the microdialysis ethanol technique and (133)Xe clearance. Clin Sci 1994; 86: 15-25.

77. Hickner RC. Microdialysis in skeletal muscle: development and application of the microdialysis ethanol technique (Thesis).

Stockholm, Karolinska Institutet
1995.

78. Arner P, Liljeqvist L und Ostman J. Metabolism of mono- and diacylglycerols in subcutaneous adipose tissue of obese and normal-weight subjects. Acta Med Scand 1976; 200: 187-194.

79. Steinberg D, Vaughan M und Margolis S. Studies of triglyceride-biosynthesis in homogenates of adipose tissue. J Biol Chem 1961; 236: 1631-1637.

80. Jansson PA, Smith U und Lönnroth P. Evidence for lactate production by human adipose tissue in vivo. Diabetologia 1990; 33: 253-256.

81. Lafontan M und Arner P. Application of in situ microdialysis to measure metabolic and vascular responses in adipose tissue. Current Techniques 1996; 17: 309-313.

82. Bolinder J, Ungerstedt U und Arner P. Microdialysis measurement of the absolute glucose concentration in subcutaneous adipose tissue allowing glucose monitoring in diabetic patients. Diabetologia 1992; 35: 1177-1180.

83. Rosdahl H, Hamrin K, Ungerstedt U et al. Metabolites levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion flow. Am J Physiol 1998; 274: E936-E945.

84. Rodbell M. Metabolism in isolated fat cells. J Biol Chem 1964; 239: 375-380.

85. Rebuffe-Scrive M, Eldh J, Hafstrom LO et al . Metabolism of mammary, abdominal, and femoral adipocytes in women before and after menopause. Metabolism 1986; 35: 792-797.

86. Janke J, Engeli S, Gorzelniak K et al. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptor. Diabetes 2002; 51: 1699-1707.

87. Morimoto C, Kameda K, Tsujita T et al. Relationship between lipolysis induced by various lipolytic agents and hormone-sensitive lipase in rat fat cells. J Lipid Res 2001; 42: 120-127.

88. Krebs HA. Hoppe-Seyler´s Z. Physiol Chem 1932; 210: 33-66.

89. Jolly SR, Lombardo YB, Lech JJ et al. Effect of aging and cellularity on lipolysis in isolated mouse fat cells. J Lipid Res 1980; 21: 44-52.

90. Hartmann AD, Cohen AL, Richane C et al. Lipolytic response and adenyl cyclase activity of rat adipocytes as related to cell size. J Lipid Res 1971; 12: 498-505.

91. Bernt E und Gutmann I. Ethanol determination with alcohol dehydrogenase and NAD. Bergmeyer HU (Hersg.), Methods of enzymatic analysis, Verlag Chemie 1974; 1499-1505.

92. Felig P. Amino acid metabolism in man. Annu Rev Biochem 1975; 44: 933-955.

93. Cabassi A, Bergamaschi E und Mutti A. Monitoring norepinephrine levels by microdialysis in the white aipose tissue of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl 1995; 22: S83-S85.

94. Bairras C, Ferrand C und Atgie C. Effect of tyramine, a dietary amine, on glycerol and lactate release by isolated adipocytes from old rats. J Physiol Biochem 2003; 59: 161-167.

95. Arner P, Kriegholm E und Engfeldt P. In situ studies of catecholamine-induced lipolysis in human adipose tissue using microdialysis. J Pharmacol Exp Ther 1990; 254: 284-288.

96. Arner P, Kriegholm E und Engfeldt P. In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue. J Pharmacol Exp Ther 1991; 259: 317-322.

97. Galitzky J, Lafontan M, Nordenstrom J et al. Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue. J Clin Invest 1993; 91: 1997-2000.

98. Boschmann M, Jordan J, Schmidt S et al. Gender-specific response to interstitial angiotensin II in human white adipose tissue. Horm Metab Res 2002; 34: 726-730.

99. Boschmann M, Krupp G, Luft FC et al. In vivo response to alpha-1 adrenoceptor stimulation in human white adipose tissue. Obes Res 2002; 10: 555-558.

100. Quisth V, Enoksson S, Blaak E et al. Major differences in noradrenaline action on lipolysis and blood flow rates in skeletal muscle and adipose tissue in vivo. Diabetologia 2005; 48: 946-953.

101. Millet L, Barbe P, Lafontan M et al. Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue. J Appl Physiol 1998; 85: 181-188.

102. Flechtner-Mors M, Jenkinson CP, Ala A et al. In vivo alpha-1 adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects. J Pharmacol Exp Ther 2002; 301: 229-233.

103. Jacob G, Costa F, Vincent S et al. Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration. Circulation 2003; 107: 2475-2479.

104. Frisk-Holmberg M und Ostman J. Differential inhibition of lipolysis in human adipose tissue by adrenergic beta receptor blocking agents. J Pharmacol Exp Ther 1977; 200: 598-605.

105. Hellstrom L, Blaak E und Hagstrom-Toft E. Gender differences in adrenergic regulation of lipid mobilization during exercise. Int Sports Med 1996; 17: 439-447.

106. Schröder C, Adams F, Boschmann M et al. Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function. Am J Physiol Regul Integr Comp Physiol 2004; 286: 851-856.

107. Townsend RR. The effects of angiotensin II on lipolysis in humans. Metabolism 2001; 50: 468-472.

108. Hennes MM, O´Shaughnessy IM, Kelly TM et al. Insulin-resistent lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension 1996; 28: 120-126.

109. Ungerstedt U. Microdialysis in normal and injured brain. In: Kinney JM und Tucker HN (Hrsg.). Physiology, Stress, and Malnutrition.

New York: Lippincott-Raven Publishers
1997; 361-374.

110. Forssard M, Joukhadar C, Steffen C et al. Paracrine effects of angiotensin-converting enzyme and angiotensin II receptor inhibition on transcapillary glucose transport in humans. Life Sciences 2000; 66: 147-154.

111. Engfeldt P und Cassis L. Subcutaneous adipose tissue blood flow in the abdominal und femoral regions in obese women: effect of fasting. Int J Obes Relat Metab Disord 1992; 16: 875-879.

112. Kucmarski RJ, Fanelli MT und Koch GG. Ultrasonic assessment of body composition in obese adults: overcoming the limitations of the skin fold caliper. Am J Clin Nutr 1987; 45: 717-724.

113. Larsen OA, Lassen NA und Quaade F. Blood flow through human adipose tissue determined with radioactive xenon . Acta Physiol Scand 1966; 66: 337-345.

114. Nielsen SL und Larsen OA. Relationship of subcutaneous adipose tissue blood flow to thickness of subcutaneous tissue and total body fat mass. Scand J Clin Lab Invest 1973; 31: 383-388.

115. Bolinder J, Hagström E, Ungerstedt U et al. Microdialysis of subcutaneous adipose tissue in vivo for contineous glucose monitoring in man. Scand J Clin Lab Invest 1989; 49: 465-474.

116. Lönnroth P, Jansson PA, Fredholm BB et al. Microdialysis of intercellular adenosine concentration in subcutaneous tissue in humans. Am J Physiol 1989; 256: E250-E255.

117. Felländer G, Linde B und Bolinder J. Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans. Int J Obes Relat Metab Disord 1996; 20: 220-226.

118. Lieber CS. Metabolic aspects of alcoholism. MTP,

Lancaster
1977; 1-29:

119. Puddey IB, Zilkens RR, Croft KD et al. Alcohol and endothelial function: a brief review. Clin Exp Pharmacol Physiol 2001; 28: 1020-1024.

120. Strindberg L und Lönnroth P. Validation of an endogeneous reference technique for the calibration of microdialysis catheters. Scand J Clin Lab Invest 2000; 60: 205-211.

121. Orphanidou C, McCargar L, Birmingham CL et al. Accuracy of subcutaneous fat measurement: comparison of skin fold calipers, ultrasound, and computed tomography. J Am Diet Assoc 1994; 94: 855-858.

122. Wofford MR und Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004; 10: 3621-3637.

123. Regan CJ, Duckworth R, Fairhurst JA et al. Metabolic effects of low-dose dopamine infusion in normal volunteers. Clin Sci 1990; 79: 605-611.

124. Nyholm D, Nilsson Remahl AI, Dizdar N et al. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 2005; 64: 216-223.

125. Palhagen S, Lorefalt B, Carlsson M et al. Does l-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson´s disease? Acta Neurol Scand 2005; 111: 12-20.

126. Gurr MI, Jung RT, Robinson MP et al. Adipose tissue cellularity in man: the relationship between fat cell size and number, the mass and distribution of body fat and the history of weight gain and loss. Int J Obes 1982; 6: 419-436.

127. Knittle JL, Timmers K, Ginsberg Fellner F et al. The growth of adipose tissue in children and adolescents. Cross sectional and longitudinal studies of adipose cell number and size. J Clin Invest 1979; 63: 239-246.